CASTRATION RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that no longer responds to hormone therapy, as well as other solid tumors like melanoma and lung cancer. The goal was to see if the drug could shrink tumors or slow dis…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC